Showing results (11-20 of 187) with videos related to
Sort By:
Pageof 19
Statistics in Medicine|August 1, 1990
Historical and methodological developments in clinical trials at the National Cancer InstituteE A Gehan, M A SchneidermanNational Cancer Institute Monograph|April 1, 1981
Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma StudyM Tefft, R D Lindberg, E A GehanControlled Clinical Trials|December 10, 1999
A modification of Simon's optimal design for phase II trials when the criterion is median sample sizeJ J Hanfelt, R S Slack, E A GehanCancer Treatment Reports|February 1, 1980
Use of prognostic factors in analysis of historical control studiesE A Gehan, T L Smith, A U BuzdarCancer|September 26, 1997
Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology GroupW Lawrence, J R Anderson, E A Gehan, et al.Skeletal Radiology|January 1, 1992
Plain radiographic predictors of survival in treated Ewing's sarcoma. IESS CommitteeW R Reinus, E A Gehan, L A Gilula, et al.Statistics in Medicine|September 15, 1994
An optimal three-stage design for phase II clinical trialsL G Ensign, E A Gehan, D S Kamen, et al.Cancer|August 1, 1982
Prediction of remission in adult acute leukemia: development and testing of predictive modelsT L Smith, E A Gehan, M J Keating, et al.Cancer|July 1, 1990
Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisoneS S Givens, L M Fuller, F B Hagemeister, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Reducing patient eligibility criteria in cancer clinical trialsS L GeorgePageof 19